Wedbush Securities Inc Synthetic Biologics, Inc. Transaction History

Wedbush Securities Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 17, 2020	SELL	$2.7 - $6.1 $355,298 - $802,711	-131,592 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$3.9 - $5.3 $97,500 - $132,500	25,000 Added 23.45%	131,592 $67,000
Q3 2019 Oct 17, 2019	BUY	$3.9 - $5.9 $33,676 - $50,946	8,635 Added 8.82%	106,592 $48,000
Q2 2019 Aug 01, 2019	BUY	$4.9 - $6.6 $479,989 - $646,516	97,957 New	97,957 $54,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.